Therapeutic Modalities

More Topics

The Role of Single-Use Polymeric Solutions in Enabling Cell and Gene Therapy Production: Part 1: Introduction and Manufacturing Process

The Role of Single-Use Polymeric Solutions in Enabling Cell and Gene Therapy Production: Part 1: Introduction and Manufacturing Process The Role of Single-Use Polymeric Solutions in Enabling Cell and Gene Therapy Production: Part 1: Introduction and Manufacturing Process

byBio-Process Systems Alliance (BPSA)

Apr 18, 2019

A Perspective on GMPs for Cellular Therapy Commercialization

A Perspective on GMPs for Cellular Therapy Commercialization A Perspective on GMPs for Cellular Therapy Commercialization

byKimberley Buytaert-Hoefen

Apr 17, 2019

Cell and Gene Therapy Data Management: Solutions to Address Complex Challenges

Cell and Gene Therapy Data Management: Solutions to Address Complex Challenges Cell and Gene Therapy Data Management: Solutions to Address Complex Challenges

bySteve Goodman, Robert Di Scipio

Apr 17, 2019

Is the QbD Toolbox Ready for Cell and Gene Therapies? Integrating Patient Outcomes into Manufacturing Cell and Gene Therapy Bioproducts

Sponsored Content

Is the QbD Toolbox Ready for Cell and Gene Therapies? Integrating Patient Outcomes into Manufacturing Cell and Gene Therapy Bioproducts Is the QbD Toolbox Ready for Cell and Gene Therapies? Integrating Patient Outcomes into Manufacturing Cell and Gene Therapy Bioproducts

byJose Menezes, Madalena R. Testasand 3 more

Apr 12, 2019

April 2019 April 2019

Apr 1, 2019

Monoclonal Antibodies: Beyond the Platform in Manufacturing

Monoclonal Antibodies: Beyond the Platform in Manufacturing Monoclonal Antibodies: Beyond the Platform in Manufacturing

byAlison Center, Cheryl Scott

Mar 29, 2019

Apparent Matrix Effects in an Iduronate 2-Sulfatase Specific Activity Assay

Apparent Matrix Effects in an Iduronate 2-Sulfatase Specific Activity Assay

Apparent Matrix Effects in an Iduronate 2-Sulfatase Specific Activity Assay

+1

byTakayuki Nakano, Brenda Kelloggand 1 more

Partnerships in Immunotherapy for the Future of Cancer Treatment

Partnerships in Immunotherapy for the Future of Cancer Treatment

Partnerships in Immunotherapy for the Future of Cancer Treatment

Tangential-Flow Electrophoresis: Investigation of Factors Involved in an Effective Separation of Human Serum Albumin from Human Plasma

Separation/Purification

Tangential-Flow Electrophoresis: Investigation of Factors Involved in an Effective Separation of Human Serum Albumin from Human Plasma

Tangential-Flow Electrophoresis: Investigation of Factors Involved in an Effective Separation of Human Serum Albumin from Human Plasma

+2

byNg Kheng Tee, Benjamin Limand 2 more

A Brief History of Adherent Cell Culture: Where We Come From and Where We Should Go

A Brief History of Adherent Cell Culture: Where We Come From and Where We Should Go

A Brief History of Adherent Cell Culture: Where We Come From and Where We Should Go

Messenger RNA Drugs: Engaging the Machinery of Patients' Cells to Therapeutic Effect

Messenger RNA Drugs: Engaging the Machinery of Patients' Cells to Therapeutic Effect

Messenger RNA Drugs: Engaging the Machinery of Patients' Cells to Therapeutic Effect

byAlison Center, S. Anne Montgomery

Development and Biomanufacturing Strategies for Next-Generation Antibody-Drug Conjugates

Development and Biomanufacturing Strategies for Next-Generation Antibody-Drug Conjugates

Development and Biomanufacturing Strategies for Next-Generation Antibody-Drug Conjugates

byAad van de Leur, Michel Eppink

Biopharmaceutical Characterization, <br>Part 1: Biological Assays — <br>A Conference Report

Biopharmaceutical Characterization, Part 1: Biological Assays — A Conference Report

Biopharmaceutical Characterization, Part 1: Biological Assays — A Conference Report

Standardizing Human MSCs As Critical Raw Materials in Cell Therapy Products: Streamlining Clinical Translation

Standardizing Human MSCs As Critical Raw Materials in Cell Therapy Products: Streamlining Clinical Translation

Standardizing Human MSCs As Critical Raw Materials in Cell Therapy Products: Streamlining Clinical Translation

+1

byMithu Majumder, Tim Olsenand 1 more

Rolling with the ‘Tides: Elucidating the Role of Peptides and Oligonucleotides in the Biopharmaceutical Industry

Rolling with the ‘Tides: Elucidating the Role of Peptides and Oligonucleotides in the Biopharmaceutical Industry

Rolling with the ‘Tides: Elucidating the Role of Peptides and Oligonucleotides in the Biopharmaceutical Industry

+2

byS. Anne Montgomery, Dan Stantonand 2 more

The Need for Adherent Cell Manufacturing: Production Platform and Media Strategies Drive Cell Production Economics

The Need for Adherent Cell Manufacturing: Production Platform and Media Strategies Drive Cell Production Economics

The Need for Adherent Cell Manufacturing: Production Platform and Media Strategies Drive Cell Production Economics

byJon A. Rowley, S. Anne Montgomery

Partnerships in Immunotherapy: Working Together to Take Cancer Treatment to the Next Level

Partnerships in Immunotherapy: Working Together to Take Cancer Treatment to the Next Level

Partnerships in Immunotherapy: Working Together to Take Cancer Treatment to the Next Level

Biological Stealth Bombers: Potency, Regulatory, and Bioprocessing Concerns of Antibody–Drug Conjugates

Product Characterization

Biological Stealth Bombers: Potency, Regulatory, and Bioprocessing Concerns of Antibody–Drug Conjugates

Biological Stealth Bombers: Potency, Regulatory, and Bioprocessing Concerns of Antibody–Drug Conjugates

+1

byUlrike Herbrand, Christopher Sucatoand 1 more

Process Analytics and Intermediate Purification of Bispecific Antibodies with a Non-Affinity Platform

Sponsored Content

Process Analytics and Intermediate Purification of Bispecific Antibodies with a Non-Affinity Platform

Process Analytics and Intermediate Purification of Bispecific Antibodies with a Non-Affinity Platform

+4

byJudith Vajda, Jean-Francois Depoisierand 4 more

eBook: Scalable Cell-Based Immunotherapy Manufacture: A Comparison of Single-Use Agitated and Static Expansion Technologies

eBook: Scalable Cell-Based Immunotherapy Manufacture: A Comparison of Single-Use Agitated and Static Expansion Technologies

eBook: Scalable Cell-Based Immunotherapy Manufacture: A Comparison of Single-Use Agitated and Static Expansion Technologies

+1

byMike Delahaye, Henrieta Fraserand 1 more

Cell-Culture–Based Influenza Vaccine Manufacturing: Evaluation of Near-Infrared Spectroscopy for In-Line Determination of Virus Titers

Cell-Culture–Based Influenza Vaccine Manufacturing: Evaluation of Near-Infrared Spectroscopy for In-Line Determination of Virus Titers

Cell-Culture–Based Influenza Vaccine Manufacturing: Evaluation of Near-Infrared Spectroscopy for In-Line Determination of Virus Titers

byLucas Vann, John D. Sheppard

The Effect of Albumin on Viability in Stem Cell Therapy

Sponsored Content

The Effect of Albumin on Viability in Stem Cell Therapy

The Effect of Albumin on Viability in Stem Cell Therapy

byPhil Morton, Daniel Shelly

Accelerated Development, Manufacturing and Monitoring of Viral Vectors

Sponsored Content

Accelerated Development, Manufacturing and Monitoring of Viral Vectors

Accelerated Development, Manufacturing and Monitoring of Viral Vectors

byBPI Contributor

Manufacturing Automation for Patient-Scale Cell Therapies

Sponsored Content

Manufacturing Automation for Patient-Scale Cell Therapies

Manufacturing Automation for Patient-Scale Cell Therapies

Acoustic Cell Processing: An Innovation in Cell-Therapy Manufacturing

Sponsored Content

Acoustic Cell Processing: An Innovation in Cell-Therapy Manufacturing

Acoustic Cell Processing: An Innovation in Cell-Therapy Manufacturing

byRichard Grant

Feeding the Demand for Cell and Gene Therapy Production

Feeding the Demand for Cell and Gene Therapy Production

Feeding the Demand for Cell and Gene Therapy Production

The Development of a Next Generation Antibody–Drug Conjugate (ADC)

Sponsored Content

The Development of a Next Generation Antibody–Drug Conjugate (ADC)

The Development of a Next Generation Antibody–Drug Conjugate (ADC)

byMichelle Zengh

Thinking Outside the Bag: Single-Use Technology Can Drive Innovation at the Benchtop Scale

Sponsored Content

Thinking Outside the Bag: Single-Use Technology Can Drive Innovation at the Benchtop Scale

Thinking Outside the Bag: Single-Use Technology Can Drive Innovation at the Benchtop Scale

byCristy Botens

eBook: Manufacturing CAR-T Cell Therapies — Insights and Challenges

eBook: Manufacturing CAR-T Cell Therapies — Insights and Challenges

eBook: Manufacturing CAR-T Cell Therapies — Insights and Challenges

+2

byLauren R. Schoukroun-Barnes, Joseph Riningerand 2 more

Demonstrating Scalable T-Cell Expansion in Stirred-Tank Bioreactors

Demonstrating Scalable T-Cell Expansion in Stirred-Tank Bioreactors

Demonstrating Scalable T-Cell Expansion in Stirred-Tank Bioreactors

+3

byAlex Klarer, David Smithand 3 more

Accelerating Vaccine Production Using a Nonviral Enabling Technology for Cell Engineering

Sponsored Content

Accelerating Vaccine Production Using a Nonviral Enabling Technology for Cell Engineering

Accelerating Vaccine Production Using a Nonviral Enabling Technology for Cell Engineering

eBook: The Future of Monoclonal Antibody Manufacturing — Incremental Improvement or Industrial Revolution?

eBook: The Future of Monoclonal Antibody Manufacturing — Incremental Improvement or Industrial Revolution?

eBook: The Future of Monoclonal Antibody Manufacturing — Incremental Improvement or Industrial Revolution?

byDan Stanton, Managing editor

eBook: The Commercial Expression Systems Market — What Has Changed in the Past Decade

Expression Platforms

eBook: The Commercial Expression Systems Market — What Has Changed in the Past Decade

eBook: The Commercial Expression Systems Market — What Has Changed in the Past Decade

byRonald A. Rader

Directed Differentiation of cGMP Compliant Human Induced Pluripotent Stem Cells Into Clinically Relevant Specialized Cells From All Three Germ Layers

Sponsored Content

Directed Differentiation of cGMP Compliant Human Induced Pluripotent Stem Cells Into Clinically Relevant Specialized Cells From All Three Germ Layers

Directed Differentiation of cGMP Compliant Human Induced Pluripotent Stem Cells Into Clinically Relevant Specialized Cells From All Three Germ Layers

Cost Analysis of Cell Therapy Manufacture: Autologous Cell Therapies, Part 2

Cost Analysis of Cell Therapy Manufacture: Autologous Cell Therapies, Part 2

Cost Analysis of Cell Therapy Manufacture: Autologous Cell Therapies, Part 2

+1

byAdriana G. Lopes, Andrew Sinclairand 1 more